Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "Small Cell Lung Carcinoma"

Clinical trialCLINICALTRIALSToday

Trial Now Recruiting: French National Database of Rare Dermatological Cancers (NCT03210935)

Researchers in France are looking for 9,000 patients with three rare types of skin cancer: Merkel cell carcinoma, advanced basal cell carcinoma, and adnexal tumors of the skin. This study will collect information about how these cancers develop, how they respond to treatment, and how they affect patients' lives. The goal is to better understand these uncommon cancers so doctors can improve care in the future.

WHY IT MATTERSIf you have been diagnosed with Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, or cutaneous adnexal carcinoma, you may be eligible to join this large French national study that could help shape future treatment approaches for these poorly understood skin cancers.
→ You can act on thisMerkel cell carcinomaAdvanced basal cell carcinomaAdnexal tumor of skin
Clinical trialUNITERAREMay 13

New Recruiting Trial: Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Researchers are testing a new treatment approach for clear cell renal cell carcinoma, a type of kidney cancer. The study combines two types of drugs: immunotherapy (which helps your immune system fight cancer) and a targeted therapy drug (TKI) that blocks specific cancer growth signals. This trial is now accepting patients and will test whether giving these drugs before and after surgery helps patients live longer.

WHY IT MATTERSThis trial is now recruiting patients with clear cell renal cell carcinoma at a major Chinese hospital — if you have this kidney cancer diagnosis, you may be eligible to access experimental combination treatment before standard treatment options.
→ You can act on thisclear cell renal cell carcinoma
Clinical trialUNITERAREMay 1

New Recruiting Trial: Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy

Researchers are looking for kidney cancer patients whose tumors shrank significantly or disappeared after immunotherapy treatment. This new trial will study whether removing the original kidney after successful immunotherapy helps prevent the cancer from coming back. The study starts in May 2026 and is currently accepting patients.

WHY IT MATTERSThis trial offers metastatic renal cell carcinoma patients who achieved complete or major response to immunotherapy a chance to participate in research that could determine whether surgical removal of the primary kidney improves long-term outcomes.
→ You can act on thismetastatic renal cell carcinomametastatic kidney cancer

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases